Eversyn GmbH

eversyn, a spin-off of the Max Planck Institute Magdeburg, pioneers cell-free biosynthesis, advancing beyond precision fermentation. They design multi-enzyme pathways for the efficient production of activated sugars. This patented technology breakthrough underpins their unique commercial feasibility for many high-value glycans, notably complex human milk oligosaccharides and tailored therapeutic protein glycosylation.